Search
for

    Sort by

    Research 301–330 of 1000+

    1. When hair dig into the brain, JAKi , may help! Journal of the European Academy of Dermatology and Venereology · 2026
    2. 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata Journal of Investigative Dermatology · 2026
    3. Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients? Cosmoderma · 2026
    4. Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata Quality in Sport · 2026
    5. 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM Journal of the American Academy of Dermatology · 2026
    6. Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care Preprints.org · 2026
    7. Alopecia areata: current concepts Wiener klinische Wochenschrift · 2026
    8. Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms Eurasian Journal of Medicine · 2026
    9. Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review Dove Medical Press (Taylor and Francis Group) · 2026
    10. Assessment and treatment of adolescent hair loss Current Opinion in Pediatrics · 2026
    11. HX17 The fortunate side effect: serendipity and therapeutic innovation in dermatology British Journal of Dermatology · 2026
    12. Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study Acta Dermato Venereologica · 2026
    13. Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets Life · 2026
    14. MODERN TREATMENT APPROACHES FOR ALOPECIA: CURRENT ADVANCES AND FUTURE PERSPECTIVES Zenodo (CERN European Organization for Nuclear Research) · 2026
    15. MODERN TREATMENT APPROACHES FOR ALOPECIA: CURRENT ADVANCES AND FUTURE PERSPECTIVES Zenodo (CERN European Organization for Nuclear Research) · 2026
    16. S3 guideline diagnostics and therapy in alopecia areata – Part 2: Therapy, psychosocial and cosmetic support JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2026
    17. Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis Clinical Journal of Gastroenterology · 2026
    18. TOFACITINIB IN OVERLAPPING AUTOIMMUNE AND AUTOINFLAMMATORY DISORDERS: A CASE REPORT OF A DUAL GRAHAM-LITTLE-PICCARDI-LASSEUR SYNDROME AND HIDRADENITIS SUPPURATIVA Case Reports in Dermatology · 2026
    19. Clinical positioning and future prospects of JAK inhibitors in alopecia areata Expert Opinion on Pharmacotherapy · 2026
    20. CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW International Journal of Innovative Technologies in Social Science · 2026
    21. Editorial: Exploring innovative therapies for rare inflammatory skin diseases Frontiers in Medicine · 2026
    22. Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy Biomedicines · 2026
    23. Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis Clinical Cosmetic and Investigational Dermatology · 2026
    24. Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis SHILAP Revista de lepidopterología · 2026
    25. UHPLC-Q-Orbitrap HRMS-based Metabolomics and In Silico Studies on 5-α-Reductase, JAK1, JAK2, and JAK3 of <i>Albizia saponaria</i> L.: Application to Alopecia Tropical Journal of Natural Product Research · 2026
    26. Alopecia and Mental Health: Psychosocial Burden, Neuroendocrine Mechanisms, and Therapeutic Implications Zenodo (CERN European Organization for Nuclear Research) · 2026
    27. Alopecia and Mental Health: Psychosocial Burden, Neuroendocrine Mechanisms, and Therapeutic Implications Zenodo (CERN European Organization for Nuclear Research) · 2026
    28. Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study Clinical Drug Investigation · 2026
    29. The Economic Burden of Alopecia Areata: Evidence from a Survey in Norway and Sweden Acta Dermato Venereologica · 2026
    30. Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations International Journal of Dermatology · 2026